DUBLIN, Ireland, Sept. 12, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that Roger Boissonneault, President and Chief Executive Officer, and Paul Herendeen, Executive Vice President and Chief Financial Officer, are scheduled to present at the 2012 UBS Global Life Sciences Conference on Wednesday, September 19 th at 10:00 a.m. EDT.
The CompanyWarner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the pharmaceutical markets, primarily in North America. The Company is fully integrated with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G
CONTACT: Emily Hill Investor Relations 973-907-7084 Emily.Hill@wcrx.com